Summary
Buprenorphine (15 µg/kg b.wt. per hour) distinctly reduced pain sensitivity in acute 3% sodium-taurocholate pancreatitis in male Wistar rats without interfering with the course of the disease. This was seen by assessment of enzyme elevation in serum and ascites and by histological evaluation of the pancreas. Buprenorphine is therefore recommended for animal experiments to study the effect of therapeutic principles in acute pancreatitis.
Similar content being viewed by others
References
Blamey SL, Finlay IG, Carter DC, Imrie CW (1984) Analgesia in acute pancreatitis: Comparison of buprenorphine and pethidine. Br Med J 288:1494–1495
Erlanger BF, Kokowsky N, Cohen W (1961) The preparation and properties of two chromogenic substrates of trypsin. Arch Biochem Biophys 95:271–278
Heel RC, Brogden RN, Speight TM, Avery GS (1979) Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs 17:81–110
Lankisch PG (1984) Acute and chronic pancreatitis. An update on management. Drugs 28:554–564
Lankisch PG, Winckler K, Bokermann M, Schmidt H, Creutzfeldt W (1974) The influence of glucagon on acute experimental pancreatitis in the rat. Scand J Gastroenterol 9:725–729
Rick W (1969) Kinetischer Test zur Bestimmung der Serumlipaseaktivität. Z Klin Chem Klin Biochem 7:530–539
Rick W, Stegbauer HP (1970) α-Amylase. Messung der reduzierenden Gruppen. In: Bergmeyer HU (Hrsg) Methoden der enzymatischen Analyse, Bd 1. Verlag Chemie, Weinheim, S 848–853
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wereszczyńska-Siemiatkowska, U., Nebendahl, K., Pohl, U. et al. Influence of buprenorphine on acute experimental pancreatitis. Res. Exp. Med. 187, 211–216 (1987). https://doi.org/10.1007/BF01852085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01852085